help button home button Biophys. J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Biophys. J. BioFAST: First Published August 12, 2005. doi:10.1529/biophysj.105.066100
© 2005 by the Biophysical Society.


A more recent version of this article appeared on November 1, 2005.
This Article
Right arrow Full Text (Rapid PDF)
Right arrow supplemental
Right arrow All Versions of this Article:
biophysj.105.066100v1
89/5/3312    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Author home page(s):
Xavier Siebert
Betty A. Eipper
Richard E. Mains
Sean T. Prigge
Ninian J. Blackburn
L. Mario Amzel
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Siebert, X.
Right arrow Articles by Amzel, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Siebert, X.
Right arrow Articles by Amzel, L. M.

PROTEINS

The catalytic copper of Peptidylglycine alpha-Hydroxylating Monooxygenase also plays a critical structural role

Xavier Siebert 1, Betty A. Eipper 2, Richard E. Mains 2, Sean T. Prigge 3, Ninian J. Blackburn 4 and L. Mario Amzel 1*

1 Johns Hopkins School of Medicine
2 University of Connecticut Health Center
3 Johns Hopkins School of Public Health
4 Oregon Health and Science University

* To whom correspondence should be addressed. E-mail: mario{at}neruda.med.jhmi.edu.

Submitted on May 11, 2005
Revised on July 8, 2005
Accepted on 19 July 2005


   Abstract
Many bioactive peptides require amidation of their carboxy terminus to exhibit full biological activity. Peptidylglycine alpha-Hydroxylating Monooxygenase (PHM; EC 1.14.17.3), the enzyme that catalyzes the first of the two steps of this reaction, is composed of two domains, each of which binds one copper atom (CuH and CuM). The CuM site includes Met314 and two His residues as ligands. Mutation of Met314 to Ile inactivates PHM, but has only a minimal effect on the EXAFS spectrum of the oxidized enzyme, implying that it contributes only marginally to stabilization of the CuM site. To characterize the role of Met314 as a CuM ligand, we determined the structure of the M314I-PHM mutant. Since the mutant protein failed to crystallize in the conditions of the original wild-type protein, this structure determination required finding a new crystal form. The M314I-PHM mutant structure confirms that the mutation does not abolish CuM binding to the enzyme, but causes other structural perturbations that affect the overall stability of the enzyme and the integrity of the CuH site. To eliminate possible effects of crystal contacts, we redetermined the structure of wt-PHM in the M314I-PHM crystal form and showed that it does not differ from the structure of wt-PHM in the original crystals. M314I-PHM was also shown to be less stable than wt-PHM by Differential Scanning Calorimetry (DSC). Both structural and calorimetric studies point to a structural role for the CuM site, in addition to its established catalytic role.

Key Words: X-ray crystallography, copper enzymes, electron-transfer, monooxygenase, protein structure







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2005 by the Biophysical Society.